)
Thomas Carlsen
CEO,
Novo Nordisk Cellerator
Sessions
-
03-Sep-2025PlenaryThe state of the CGT industry & turning the future into action
-
03-Sep-2025Theatre 1Spotlight: Overcoming barriers in first-in-human trials